SEC Form 4 · accession 0001209191-18-056808
Iterum Therapeutics plc · ITRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Chin
Director
Period of report
Oct 30, 2018
Accepted (ET)
Nov 1, 2018 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659323
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Oct 30, 2018 | P | 58,000 | $6.10 | A | 1,089,903 | I | By Arix Bioscience Holdings Ltd. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is an Investment Director for Arix Bioscience Holdings Ltd.